Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP905884.RASsUmsxZT8XbwhN3sb4K7U0Ibg2TJqB4daIfMWnDIOBA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP905884.RASsUmsxZT8XbwhN3sb4K7U0Ibg2TJqB4daIfMWnDIOBA130_assertion type Assertion NP905884.RASsUmsxZT8XbwhN3sb4K7U0Ibg2TJqB4daIfMWnDIOBA130_head.
- NP905884.RASsUmsxZT8XbwhN3sb4K7U0Ibg2TJqB4daIfMWnDIOBA130_assertion wasGeneratedBy ECO_0000203 NP905884.RASsUmsxZT8XbwhN3sb4K7U0Ibg2TJqB4daIfMWnDIOBA130_provenance.
- NP905884.RASsUmsxZT8XbwhN3sb4K7U0Ibg2TJqB4daIfMWnDIOBA130_assertion wasDerivedFrom befree-2016 NP905884.RASsUmsxZT8XbwhN3sb4K7U0Ibg2TJqB4daIfMWnDIOBA130_provenance.
- NP905884.RASsUmsxZT8XbwhN3sb4K7U0Ibg2TJqB4daIfMWnDIOBA130_assertion SIO_000772 21715317 NP905884.RASsUmsxZT8XbwhN3sb4K7U0Ibg2TJqB4daIfMWnDIOBA130_provenance.
- NP905884.RASsUmsxZT8XbwhN3sb4K7U0Ibg2TJqB4daIfMWnDIOBA130_assertion evidence source_evidence_literature NP905884.RASsUmsxZT8XbwhN3sb4K7U0Ibg2TJqB4daIfMWnDIOBA130_provenance.
- NP905884.RASsUmsxZT8XbwhN3sb4K7U0Ibg2TJqB4daIfMWnDIOBA130_assertion description "[In the present study, we examined 811 consecutive cases of B-cell lymphoproliferative disorders (B-LPDs), and demonstrated CD160 expression in 98% (590 of 600) of chronic lymphocytic leukemia (CLL) cases, 100% (32 of 32) of hairy cell leukemia (HCL) cases, 15% (5 of 34) of mantle cell lymphoma (MCL) in the leukemic phase, and 16% (23 of 145) of other B-LPD cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP905884.RASsUmsxZT8XbwhN3sb4K7U0Ibg2TJqB4daIfMWnDIOBA130_provenance.